Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053169/
https://www.ncbi.nlm.nih.gov/pubmed/30038524
http://dx.doi.org/10.2147/DHPS.S175655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053169/
https://www.ncbi.nlm.nih.gov/pubmed/30038524
http://dx.doi.org/10.2147/DHPS.S175655

Ejemplares similares